Position in LLY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$6,033,133
+$1,378,178 QoQ
Shares Held
5,030
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,569
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $18,529,171 across 15 Drug Manufacturers - General names. LLY ranks #1 (32.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,030 | $6,033,133 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,868 | $2,167,538 | |
| 3 | ABBV |
AbbVie Inc.
|
8,498 | $2,138,436 | |
| 4 | JNJ |
Johnson & Johnson
|
7,490 | $1,902,235 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,368 | $1,815,253 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,390 | $1,520,591 | |
| 7 | SNY |
Sanofi
|
14,570 | $621,556 | |
| 8 | AZN |
Astrazeneca PLC
|
3,264 | $618,919 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,033,133 | 5,030 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $4,654,955 | 5,061 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,384,187 | 1,288 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $525,707 | 689 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,535 | 52 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,841,661 | 7,073 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,661,076 | 7,333 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,675,557 | 7,535 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,415,507 | 9,295 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,231,138 | 9,295 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,531,330 | 2,627 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $666,578 | 1,241 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $581,066 | 1,239 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,272 | 27 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,104,836 | 3,020 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $953,235 | 2,948 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $839,107 | 2,588 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $859 | 3 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $828 | 3 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $693 | 3 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $918 | 4 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,802 | 15 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,363 | 14 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,072 | 14 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,796,457 | 10,942 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,525 | 11 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||